Small animal B. Anthracis spore challenge model
Ended Awarded Last action
- Contract number
- 00266200309C0004266030061
- Awardee
-
Battelle Memorial Institute UEI F125YU6SWK59
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $17,679,716
Award facts
- Contract value 168% obligated
- $10,503,952.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- NIAID DEA OA Acquisitions National Institutes of Health, Department of Health and Human Services
- NAICS code
- Not on record
- PSC
- AJ12 General Science And Technology R&D Services; General Science And Technology; Applied Research
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 6 offers
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Columbus, OH 43201, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Funding Only Action | $2,358,124 | |
| Change Order | $8,145,828 | |
| Original award | $7,175,764 |
About this award
Battelle Memorial Institute, a Columbus, Ohio-based nonprofit research and development organization, was awarded a $10.5 million delivery order contract by the National Institute of Allergy and Infectious Diseases (NIAID) on September 15, 2003. This cost-plus-fixed-fee contract, which was not issued under a set-aside designation, supports the development and maintenance of a small animal Bacillus anthracis spore challenge model through September 30, 2012. The work will be performed at Battelle's Columbus, Ohio facility and represents part of NIAID's broader efforts to advance biodefense research capabilities and medical countermeasures against biological threats.
The contract leverages Battelle's extensive expertise in chemical and biological defense testing and specialized laboratory services. As a delivery order vehicle, this award provides NIAID with flexible access to Battelle's technical capabilities for developing animal models critical to evaluating vaccine efficacy and therapeutic interventions against anthrax. This engagement demonstrates Battelle's role as a key scientific partner to federal health and defense agencies in supporting research initiatives essential to national biosecurity and public health preparedness.
Quick answers
Who was awarded contract 00266200309C0004266030061?
00266200309C0004266030061 was awarded to Battelle Memorial Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 15, 2003.
How much is contract 00266200309C0004266030061 worth?
The government has obligated $17,679,716 on 00266200309C0004266030061. Its current value, with exercised options, is $10,503,952.
Which agency awarded contract 00266200309C0004266030061?
National Institute of Allergy and Infectious Diseases (National Institutes of Health) awarded 00266200309C0004266030061, with funding from NIAID DEA OA Acquisitions (National Institutes of Health).
Is contract 00266200309C0004266030061 an order under another contract?
Yes. 00266200309C0004266030061 is a delivery order under 266030061, an indefinite delivery contract.
Was contract 00266200309C0004266030061 competed?
The extent of competition for 00266200309C0004266030061 was full and open competition. The government received 6 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award